BEIJING, Jan. 7, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital, today announced that on January 7, 2014, its Board of Directors declared a special cash dividend of $0.24 per ordinary share (or $0.72 per American Depositary Share ("ADS")) on the Company's outstanding ordinary shares. The total expense for the special dividend is expected to be approximately $32.2 million, based on 134,018,937 ordinary shares outstanding as of September 30, 2013. Each ADS represents three ordinary shares of the Company.
The dividends are payable on January 30, 2014, to shareholders of record at the close of business on January 20, 2014.
Dr. Jianyu Yang, Chairman and CEO of the Company, said, "The Board of Directors declared this special dividend to provide shareholders with a tangible recognition of our good growth and solid financial performance. Concord Medical is well positioned to maintain its leadership in the fast-growing healthcare services sector in China. The Company is expected to return exceptional values to shareholders, while maintain a stable growth prospect in our business."
About Concord Medical
Concord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in China, measured by revenues and the number of centers in operation and is the parent of Chang'an Hospital. As of September 30, 2013, the Company operated a network of 144 centers with 78 hospital partners that spanned 55 cities and 24 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.
For more information, please contact:
Mr. Adam J. Sun (Chinese and English)
+86 10 5957 5266
adam.sun@concordmedical.com
Mr. Ting Jia (Chinese and English)
+86 10 5903 6688 (ext. 809)
ting.jia@concordmedical.com
Ms. Gloria Huang (Chinese and English)
+86 10 5903 6688 (ext. 639)
gloria.huang@concordmedical.com
ICR Inc.
In China:
Ms. Rene Jiang
+86 10 6583-7521
rene.jiang@icrinc.com
In the United States:
Mr. William Zima
+1 203-682-8233
William.Zima@icrinc.com
SOURCE Concord Medical Services Holdings Limited
